SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Clinical trial NCT06055348 · UNKNOWN

Trial details

NCT number: NCT06055348
Sponsor: Biocity Biopharmaceutics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Serous Ovarian Cancer Advanced Ovarian Cancer

Start date: 2023-10-30
Primary completion: 2025-08-30
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.